![](https://endpts.com/wp-content/uploads/2022/07/Michael-Davidson-NewAmsterdam-via-Caladrius-tile.jpg)
Michael Davidson, NewAmsterdam Pharma CEO (Caladrius)
NewAmsterdam says former Amgen cardio drug reduces heart disease risk factor
A Dutch biotech has proved its resurrected Amgen drug is capable of significantly lowering “bad” cholesterol in a handful of mid-stage trials in recent years …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.